Clinical trial
A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For…
NCT00038545 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00038545 |
|---|---|
| Title | A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma |
| Official title | A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Patients With Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | Filgrastim SD/01, Paclitaxel, Topotecan |
| Enrollment | 25 |
| Start date | May 18, 2001 |
| Primary completion | Apr 27, 2004 |
| Completion | Apr 27, 2004 |
| First posted | Jun 3, 2002 |
| Last update posted | Oct 30, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: